Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Goodman

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Nutrition and Cancer|October 9, 2001
Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trialsM L Neuhouser, A R Kristal, R E Patterson, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group studyT D Brown, P J Goodman, T R Fleming, et al.
Anti-Cancer Drugs|April 1, 1995
A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, T R Fleming, P J Goodman, et al.
Anti-Cancer Drugs|February 1, 1993
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group studyT D Brown, P J Goodman, T Fleming, et al.
Investigational New Drugs|February 1, 1993
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712W H Harvey, T R Fleming, P J Goodman, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and designE A Klein, I M Thompson, S M Lippman, et al.
The Journal of Urology|September 8, 2001
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention TrialE A Klein, I M Thompson, S M Lippman, et al.
Anti-Cancer Drugs|June 1, 1992
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancersF M Muggia, T D Brown, P J Goodman, et al.
Investigational New Drugs|August 1, 1990
Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group studyJ P Kuebler, P J Goodman, T D Brown, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, P J Goodman, T Fleming, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Nutrition and Cancer|October 9, 2001
Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trialsM L Neuhouser, A R Kristal, R E Patterson, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group studyT D Brown, P J Goodman, T R Fleming, et al.
Anti-Cancer Drugs|April 1, 1995
A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, T R Fleming, P J Goodman, et al.
Anti-Cancer Drugs|February 1, 1993
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group studyT D Brown, P J Goodman, T Fleming, et al.
Investigational New Drugs|February 1, 1993
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712W H Harvey, T R Fleming, P J Goodman, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and designE A Klein, I M Thompson, S M Lippman, et al.
The Journal of Urology|September 8, 2001
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention TrialE A Klein, I M Thompson, S M Lippman, et al.
Anti-Cancer Drugs|June 1, 1992
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancersF M Muggia, T D Brown, P J Goodman, et al.
Investigational New Drugs|August 1, 1990
Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group studyJ P Kuebler, P J Goodman, T D Brown, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, P J Goodman, T Fleming, et al.
Pageof 4